Pittsburgh Event Day Volunteer Chair Kecia Scott spoke with PanCAN’s Paula Mukherjee about her journey as a caregiver and ...
Nadine: My father, Eddie, was diagnosed with pancreatic cancer in 2003. He was only 46. He passed away the following year. Paula: How did your father get diagnosed? Nadine: He was experiencing a lot ...
The U.S. Food and Drug Administration has granted approval for a new drug targeting the mutations that drive more than 90% of pancreatic cancer cases — a sweeping advance for a disease that has few ...
Editor’s Note: Chicago Advocacy Chair Joanne Zborowski spoke with PanCAN’s Paula Mukherjee about her personal connection to PanCAN’s mission and advice for others who have lost a loved one to ...
Editor’s Note: Survivor, volunteer and top PurpleStride fundraiser John Walmsley spoke with PanCAN’s Paula Mukherjee about his commitment to providing support to other survivors and passion for ...
The Pancreatic Cancer Action Network (PanCAN), the leading organization dedicated to advancing progress against pancreatic cancer, released a statement today following the full data from Revolution ...
Nota del editor: Muchos de los enlaces en esta publicación son a recursos que solamente están disponibles en inglés. Para obtener más información en español, comuníquese con el Programa de Servicios ...
I can’t think of a more exciting and hopeful time for pancreatic cancer than now. We are finally beginning to reap the benefits of decades of research into this challenging cancer. Because KRAS ...
Today, the President’s budget request (PBR) was released, and while the PBR is just that – a request – it signals the administration’s priorities for the coming fiscal year 2027, and once again, it ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...
The U.S. Food and Drug Administration (FDA) has approved a wearable medical device used in combination with a standard chemotherapy regimen for the treatment of adult patients with locally advanced ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results